Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Accumulated Depreciation (2020 - 2025)

Celcuity's (CELC) quarterly Accumulated Depreciation came in at $2.2 million in Q4 2025, up 8.38% YoY from $2.0 million in Q4 2024, and up 8.38% on a QoQ basis from $2.0 million in Q4 2024.

Analysis

Celcuity (CELC) Accumulated Depreciation (2020 - 2025) Analysis & Trends

Celcuity (CELC) has 6 years of Accumulated Depreciation data on file, last reported at $2.2 million in Q4 2025.

  • Quarterly Accumulated Depreciation rose 8.38% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 8.38% YoY) and the FY2025 annual result came in at $2.2 million, up 8.38% from the prior year.
  • Accumulated Depreciation climbed to $2.2 million in Q4 2025, from $2.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation ranged from a high of $2.2 million in Q4 2025 to a low of $1.5 million in Q4 2021.
  • A 5-year average of $1.8 million and a median of $1.9 million in 2023 frame the typical range for Accumulated Depreciation.
  • Annual changes were most pronounced in 2021 — Accumulated Depreciation rose 25.12% — and 2024, when it increased 6.98%.
  • Tracing CELC's Accumulated Depreciation over 5 years: stood at $1.5 million in 2021, then grew by 13.98% to $1.7 million in 2022, then increased by 8.3% to $1.9 million in 2023, then climbed by 6.98% to $2.0 million in 2024, then gained by 8.38% to $2.2 million in 2025.
  • The last three Accumulated Depreciation figures came in at $2.2 million (Q4 2025), $2.0 million (Q4 2024), and $1.9 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Celcuity 5.25 Bn 5.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.16 Mn
Dec 31, 2024 1.99 Mn
Dec 31, 2023 1.86 Mn
Dec 31, 2022 1.72 Mn
Dec 31, 2021 1.51 Mn
Dec 31, 2020 1.21 Mn